On July 27, 2021 Vyant Bio, Inc. ("Vyant Bio", "Company") (Nasdaq: VYNT), an emerging leader in novel drug discovery, reported that Jay Roberts, Chief Executive Officer, will present at A.G.P.’s Virtual MedTech Summer Conference hosted by Alliance Global Partners (A.G.P) on Thursday, July 29, 2021 (Press release, Vyant Bio, JUL 27, 2021, View Source [SID1234585240]). One-on-one partnering meetings will be held via the conference portal.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Roberts will highlight the Company’s updated business strategy, including progress related to integrating and accelerating the recent merger with StemoniX, Inc. to increase shareholder value. He will also elaborate on the broader corporate vision of Vyant Bio as it pertains to recent progress with biopharma companies, strategic partners, and members of the investment community. Additionally, Mr. Roberts will review the Company’s approach to identify unique therapeutics through the integration of novel human-derived biology with internally developed data science technologies and IND-enabling expertise.

For questions and inquiries regarding the conference or to register for a one-on-one meeting, please contact a registered A.G.P. representative or email A.G.P. events at [email protected].

Vyant Bio will also be available for outside virtual 1:1 meetings both during and after A.G.P’s Virtual MedTech Summer Conference. Please contact Jennifer K. Zimmons, Ph.D. [email protected] or +1 917.214.3514 for scheduling.